Howard Hughes Medical Institute’s Aflac AFL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-102
Closed -$11.2K 45
2025
Q4
$11.2K Sell
102
-2
-2% -$220 0.01% 192
2025
Q3
$11.6K Sell
104
-2
-2% -$210 0.01% 189
2025
Q2
$11.2K Buy
+106
New +$11.1K ﹤0.01% 179
2016
Q2
Sell
-2,978
Closed -$94K 162
2016
Q1
$94K Buy
+2,978
New +$88.5K 0.02% 135

Other funds holding AFL

Howard Hughes Medical Institute's AFL Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Aflac (AFL) in Q1 2026, closing a stake of 102 shares — an estimated $11.2K sold.

Howard Hughes Medical Institute first reported a position in AFL in Q1 2016 and held it in 4 quarters. The position peaked at $94K in Q1 2016. 1,658 funds tracked by Wall St. Rank hold AFL as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Aflac position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 102 Aflac shares in Q1 2026, an estimated $11.2K.
  • Howard Hughes Medical Institute first reported a position in Aflac in Q1 2016 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Aflac position peaked at $94K in Q1 2016.
  • 1,658 funds tracked by Wall St. Rank held Aflac as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.